These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 22941011

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Fibrolamellar hepatocellular carcinoma coexistent with a hepatocellular carcinoma of common type: report of a case.
    Okada K, Kim YI, Nakashima K, Tada I, Yoshida T, Kobayashi M, Yokoyama S.
    Surg Today; 1993; 23(7):626-31. PubMed ID: 7690275
    [Abstract] [Full Text] [Related]

  • 24. HGF, MET, and matrix-related proteases in hepatocellular carcinoma, fibrolamellar variant, cirrhotic and normal liver.
    Schoedel KE, Tyner VZ, Kim TH, Michalopoulos GK, Mars WM.
    Mod Pathol; 2003 Jan; 16(1):14-21. PubMed ID: 12527708
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Recent developments in biopsy diagnosis of early and undefined liver tumors].
    Longerich T, Schirmacher P.
    Z Gastroenterol; 2009 Jan; 47(1):30-6. PubMed ID: 19156590
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Telomerase as a tool for the differential diagnosis of human hepatocellular carcinoma.
    Nouso K, Urabe Y, Higashi T, Nakatsukasa H, Hino N, Ashida K, Kinugasa N, Yoshida K, Uematsu S, Tsuji T.
    Cancer; 1996 Jul 15; 78(2):232-36. PubMed ID: 8673997
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Serum concentrations of human hepatocyte growth factor is a useful indicator for predicting the occurrence of hepatocellular carcinomas in C-viral chronic liver diseases.
    Yamagamim H, Moriyama M, Matsumura H, Aoki H, Shimizu T, Saito T, Kaneko M, Shioda A, Tanaka N, Arakawa Y.
    Cancer; 2002 Aug 15; 95(4):824-34. PubMed ID: 12209727
    [Abstract] [Full Text] [Related]

  • 34. Serum VEGF as a tumor marker in patients with HCV-related liver cirrhosis and hepatocellular carcinoma.
    Mukozu T, Nagai H, Matsui D, Kanekawa T, Sumino Y.
    Anticancer Res; 2013 Mar 15; 33(3):1013-21. PubMed ID: 23482775
    [Abstract] [Full Text] [Related]

  • 35. Prediction of liver complications in patients with hepatitis C virus-related cirrhosis with and without HIV coinfection: comparison of hepatic venous pressure gradient and transient elastography.
    Pérez-Latorre L, Sánchez-Conde M, Rincón D, Miralles P, Aldámiz-Echevarría T, Carrero A, Tejerina F, Díez C, Bellón JM, Bañares R, Berenguer J.
    Clin Infect Dis; 2014 Mar 15; 58(5):713-8. PubMed ID: 24265358
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Diagnosis and differential diagnosis of hepatocellular carcinoma].
    Drebber U, Dienes HP.
    Pathologe; 2006 Jul 15; 27(4):294-9. PubMed ID: 16767425
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.